新鄉化纖(000949.SZ):“年產10萬噸高品質超細旦氨綸纖維項目一期工程”已建設完畢
格隆匯4月7日丨新鄉化纖(000949.SZ)公佈,2022年4月6日,公司第十屆董事會第二十次會議審議通過了《關於募投項目結項並將節餘募集資金永久補充流動資金的議案》,鑑於公司非公開發行股票募投項目“年產10萬噸高品質超細旦氨綸纖維項目一期工程”已建設完畢,達到預定可使用狀態,為合理配置資金、提高募集資金使用效率,結合公司當前經營情況,會議同意將上述募投項目節餘募集資金人民幣8014.32萬元(包括累計收到的銀行存款利息並扣除銀行手續費支出等,最終金額以資金轉出當日銀行結息後的餘額為準)永久補充流動資金,用於公司日常經營活動。資金劃轉完成後,公司將對相關募集資金專户進行銷户處理,對應的募集資金監管協議亦隨之終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.